Physician profile
Sammy Ho
NPI 1932299765
$194,711.34
in general payments reported to CMS, 2019-2025
31 companies · $21K in 2025
The $21K reported for 2025 was more than what 95% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $12K · 2021: $37K · 2022: $18K · 2023: $32K · 2024: $24K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $57K · Consulting Fee: $8,923 · Food and Beverage: $8,860 · Travel and Lodging: $2,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,200.00 |
| Consulting Fee | $8,922.50 |
| Food and Beverage | $8,859.52 |
| Travel and Lodging | $2,599.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $131,277.08 | 2019-2025 | Exalt Model D, General - Therapies, Axios |
| Abbvie INC. | $33,274.41 | 2019-2024 | |
| Olympus America INC. | $15,263.23 | 2019-2025 | Single Use Repositionable Clip, Visiglide, Endoclot Phs |
| Conmed Corporation | $3,567.26 | 2019-2025 | Gore Viabil, Beamer System, Hemostasis Clip |
| Wilson Cook Medical Incorporated | $2,925.00 | 2019-2020 | |
| Cook Medical LLC | $2,054.18 | 2019-2025 | Fusion, Hemospray, Echotip Insight |
| Merit Medical Systems INC | $1,179.50 | 2024-2025 | Transmaxx, Transmaxx, Esophyx |
| Pentax of America, INC. | $810.96 | 2022-2025 | Pentax Medical, C2 Cryoballoon Focal Controller, C2 Cryoballoon |
| Olympus Corporation | $797.77 | 2023 | |
| US Endoscopy | $550.00 | 2023 | |
| Micro-Tech Endoscopy USA, INC. | $548.60 | 2019-2025 | Eyemax, Dat |
| Olympus Latin America, INC. | $367.75 | 2025 | Evis Exera II Ultrasound Gastrovideoscope |
| Takeda Pharmaceuticals U.S.A., INC. | $297.15 | 2022-2025 | Entyvio, Eohilia, Gattex |
| Steris Corporation | $260.20 | 2024-2025 | |
| Fujifilm Healthcare Americas Corporation | $198.90 | 2022-2025 | Fujifilm |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $193.56 | 2019-2022 | |
| Creo Medical INC. | $181.39 | 2023-2024 | Speedboat, Speedboat Ultraslim (Sb1l) |
| Endogastric Solutions, INC | $144.33 | 2023 | Esophyx |
| Medtronic, INC. | $126.00 | 2021 | |
| Covidien Lp | $121.30 | 2019 | |
| Exact Sciences Corporation | $116.91 | 2023-2024 | Cologuard Collection Kit |
| Laborie Medical Technologies Corp. | $90.13 | 2022 | |
| Vivus LLC | $85.12 | 2025 | Pancreaze |
| Baxter Healthcare | $78.23 | 2021 | |
| Celltrion USA INC. | $62.30 | 2024 | Vegzelma |
| Janssen Biotech, INC. | $38.32 | 2025 | Tremfya |
| Ambu INC. | $36.28 | 2023 | |
| Amgen INC. | $20.82 | 2023 | Avsola, Amjevita |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.25 | 2019 | |
| Novo Nordisk INC | $13.84 | 2025 | Saxenda, Wegovy |
| Apollo Endosurgery US INC | $10.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sammy Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.